Literature DB >> 23062534

Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease.

Dennis T Ko1, Helen Guo, Harindra C Wijeysundera, Madhu K Natarajan, A Dave Nagpal, Christopher M Feindel, Kori Kingsbury, Eric A Cohen, Jack V Tu.   

Abstract

OBJECTIVES: The study assessed the appropriateness of coronary revascularization in Ontario, Canada, and examined its association with longer-term outcomes.
BACKGROUND: Although appropriate use criteria for coronary revascularization have been developed to improve the rational use of cardiac invasive procedures, it is unknown whether greater adherence to appropriateness guidelines is associated with improved clinical outcomes in stable coronary artery disease.
METHODS: A population-based cohort of stable patients undergoing cardiac catheterization was assembled from April 1, 2006, to March 31, 2007. The appropriateness for coronary revascularization at the time of coronary angiography was retrospectively adjudicated using the appropriate use criteria. Clinical outcomes between coronary revascularization and medical treatment without revascularization, stratified by appropriateness categories, were compared.
RESULTS: In 1,625 patients with stable coronary artery disease, percutaneous coronary intervention or coronary artery bypass grafting was only performed in 69% who had an appropriate indication for coronary revascularization. Coronary revascularization was associated with a lower adjusted hazard of death or acute coronary syndrome (hazard ratio [HR]: 0.61; 95% confidence interval [CI]: 0.42 to 0.88) at 3 years compared with medical therapy in appropriate patients. The rate of coronary revascularization was 54% in the uncertain category and 45% in the inappropriate category. No significant difference in death or acute coronary syndrome between coronary revascularization and no revascularization in the uncertain category (HR: 0.57; 95% CI: 0.28 to 1.16) and the inappropriate category (HR: 0.99; 95% CI: 0.48 to 2.02) was observed.
CONCLUSIONS: Using the appropriateness use criteria, we identified substantial underutilization and overutilization of coronary revascularization in contemporary clinical practice. Underutilization of coronary revascularization is associated with significantly increased risks of adverse outcomes in patients with appropriate indications.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23062534     DOI: 10.1016/j.jacc.2012.06.056

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  23 in total

1.  Exploring the Healthcare Value of Percutaneous Coronary Intervention: Appropriateness, Outcomes, and Costs in Michigan Hospitals.

Authors:  Daniel M Alyesh; Milan Seth; David C Miller; James M Dupree; John Syrjamaki; Devraj Sukul; Simon Dixon; Eve A Kerr; Hitinder S Gurm; Brahmajee K Nallamothu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

2.  Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort study.

Authors:  Jaskaran S Kang; Maria C Bennell; Feng Qiu; Merril L Knudtson; Peter C Austin; Dennis T Ko; Harindra C Wijeysundera
Journal:  CMAJ Open       Date:  2016-08-08

3.  Patient and hospital characteristics associated with inappropriate percutaneous coronary interventions.

Authors:  Paul S Chan; Sunil V Rao; Deepak L Bhatt; John S Rumsfeld; Hitinder S Gurm; Brahmajee K Nallamothu; Matthew A Cavender; Kevin F Kennedy; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2013-09-18       Impact factor: 24.094

4.  ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease : A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.

Authors:  Manesh R Patel; John H Calhoon; Gregory J Dehmer; James Aaron Grantham; Thomas M Maddox; David J Maron; Peter K Smith
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

5.  Effect of angina under-recognition on treatment in outpatients with stable ischaemic heart disease.

Authors:  Mohammed Qintar; John A Spertus; Kensey L Gosch; John Beltrame; Faraz Kureshi; Ali Shafiq; Tracie Breeding; Karen P Alexander; Suzanne V Arnold
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2016-03-25

Review 6.  Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Authors:  Kohichiro Iwasaki
Journal:  World J Cardiol       Date:  2014-04-26

Review 7.  The transition to value-based care.

Authors:  Jordan C Ray; Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2016-07-21       Impact factor: 1.900

8.  Percutaneous Coronary Intervention Utilization and Appropriateness across the United States.

Authors:  Michael P Thomas; Craig S Parzynski; Jeptha P Curtis; Milan Seth; Brahmajee K Nallamothu; Paul S Chan; John A Spertus; Manesh R Patel; Steven M Bradley; Hitinder S Gurm
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

9.  Adherence to process of care quality indicators after percutaneous coronary intervention in Ontario, Canada: a retrospective observational cohort study.

Authors:  Andrew Czarnecki; Treesa J Prasad; Julie Wang; Harindra C Wijeysundera; Asim N Cheema; Vladimír Dz̆avík; Madhu K Natarajan; Chris S Simpson; Derek Y So; Jaffer Syed; Jack V Tu; Dennis T Ko
Journal:  Open Heart       Date:  2015-02-14

10.  Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia: Secondary Analysis of the ISCHEMIA Randomized Clinical Trial.

Authors:  Harmony R Reynolds; Leslee J Shaw; James K Min; John A Spertus; Bernard R Chaitman; Daniel S Berman; Michael H Picard; Raymond Y Kwong; C Noel Bairey-Merz; Derek D Cyr; Renato D Lopes; Jose Luis Lopez-Sendon; Claes Held; Hanna Szwed; Roxy Senior; Gilbert Gosselin; Rajesh Gopalan Nair; Ahmed Elghamaz; Olga Bockeria; Jiyan Chen; Alexander M Chernyavskiy; Balram Bhargava; Jonathan D Newman; Sasa B Hinic; Joanna Jaroch; Angela Hoye; Jeffrey Berger; William E Boden; Sean M O'Brien; David J Maron; Judith S Hochman
Journal:  JAMA Cardiol       Date:  2020-07-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.